National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

telomerase: 540-548 peptide vaccine
A recombinant peptide consisting of the amino acid residues 540 to 548 of the human telomerase reverse transcriptase (hTERT). Telomerase expression has been directly linked to tumor development; its catalytic subunit is expressed in the majority of human cancer cells, but infrequently in normal cells. Vaccination with telomerase:540-548 peptide may stimulate cytotoxic T cells to recognize and kill telomerase-expressing cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Telomerase:540-548 Peptide
Abbreviation:TEL540-548



Previous:Tegretol, teicoplanin, TELCYTA, Telintra, telomerase inhibitor GRN163L
Next:teloxantrone hydrochoride, Temodar, temozolomide, Tempostatin, temsirolimus

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov